Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Erythema multiforme (EM) is an acute mucocutaneous disorder involving the skin, mouth, eyes, and genital organs. It is classified into EM minor and EM major according to the involvement of the mucosal membrane. Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) belong to EM major. Compared to EM minor, SJS presents with more severe and progressive symptoms, and has a higher mortality rate. Corticosteroids are used in the treatment of EM. We report three cases of EM (two cases of EM minor and one case of SJS) that developed during treatment with oral corticosteroid (deflazacort; Calcort®) in children with nephrotic syndrome.
Abstract
Erythema multiforme (EM) is an acute mucocutaneous disorder involving the skin, mouth, eyes, and genital organs. It is classified into EM minor and EM major according to the involvement of the mucosal membrane. Stevens-Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) belong to EM major. Compared to EM minor, SJS presents with more severe and progressive symptoms, and has a higher mortality rate. Corticosteroids are used in the treatment of EM. We report three cases of EM (two cases of EM minor and one case of SJS) that developed during treatment with oral corticosteroid (deflazacort; Calcort®) in children with nephrotic syndrome.
참고문헌 (10)
- Huff JC, "Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes", Am Acad Dermatol, 8, pp.763~775 (1983)
- Farthing P, "Mucosal disease series. Number IV. Erythema multiforme", Oral dis, 11, pp.261~267 (2005)
- Roujeau JC, "Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme", J Dermatol, 24, pp.726~729 (1997)
- Mockenhaupt M, "The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis", Expert Rev Clin Immunol, 7, pp.803~815 (2011)
- Roujeau JC, "Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis", N Engl J Med, 333, pp.1600~1607 (1995)
- Araki Y, "Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset", Am J Ophthalmol, 147, pp.1004~1011 (2009)
- Joshi N, "Deflazacort", J Postgrad Med, 55, pp.296~300 (2009)
- Nayak S, "Deflazacort versus other glucocorticoids: a comparison", Indian J Dermatol, 53, pp.167~170 (2008)
- Del Pozzo-Magana BR, "A systemic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children", J Popul Ther Clin Pharmacol, 18, pp.121~133 (2011)
- Jo DS, "Stevens-Johnson syndrome in a boy with nephritic syndrome during prednisolone therapy", Pediatr Nephrol, 18, pp.959~961 (2003)